Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
23.79
-0.27 (-1.12%)
Nov 26, 2025, 9:23 AM EST - Market open
Fresenius Medical Care AG Revenue
Fresenius Medical Care AG had revenue of 4.88B EUR in the quarter ending September 30, 2025, with 2.62% growth. This brings the company's revenue in the last twelve months to 19.64B, up 2.10% year-over-year. In the year 2024, Fresenius Medical Care AG had annual revenue of 19.34B, down -0.61%.
Revenue (ttm)
19.64B EUR
Revenue Growth
+2.10%
P/S Ratio
0.60
Revenue / Employee
176,148 EUR
Employees
111,513
Market Cap
13.89B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.34B | -117.71M | -0.61% |
| Dec 31, 2023 | 19.45B | 55.60M | 0.29% |
| Dec 31, 2022 | 19.40B | 1.78B | 10.10% |
| Dec 31, 2021 | 17.62B | -240.38M | -1.35% |
| Dec 31, 2020 | 17.86B | 382.51M | 2.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
FMS News
- 22 hours ago - Fresenius Medical Care: 'Buy' Again Following A Peak In May - Seeking Alpha
- 21 days ago - Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025 - PRNewsWire
- 22 days ago - Fresenius Medical Care beats quarterly profit estimates helped by cost cuts - Reuters
- 27 days ago - Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025 - PRNewsWire
- 2 months ago - Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement - PRNewsWire
- 2 months ago - Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment - PRNewsWire
- 3 months ago - Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework - PRNewsWire